Pharmacogenomic testing can provide clinical information about how specific variants may impact therapeutic efficacy and toxicity, as well as how to select the most appropriate drug, the optimal dose, and how to identify patients at risk for more frequent adverse drug reactions.
Learn more about the benefits and limitations of these tests in JAX’s CME/CNE courses and clinical education resources.
See our homepage to learn more about our online, live and blended education programs.
Pharmacogenomic test reports provide information about an individual's collection of genetic variants (or genotype) that cause them to metabolize or react to medicines in certain ways (phenotype). This resource provides information about common terminology and nomenclature used in pharmacogenomic test reports.
Pharmacogenomic testing helps identify genetic variants in patients that can influence treatment decisions, emphasizing the importance of pretest and post-test communication to ensure patient understanding. Before testing, patients should be informed about the benefits, limitations, and potential outcomes, such as medication adjustments based on genetic sensitivity or resistance.